Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_assertion type Assertion NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_head.
- NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_assertion description "[Molecular types and neoadjuvant chemotherapy in patients with breast cancer- while molecular shifting is more common in luminal a tumors, the pathologic complete response is most frequently observed in her-2 like tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_provenance.
- NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_assertion evidence source_evidence_literature NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_provenance.
- NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_assertion SIO_000772 25422228 NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_provenance.
- NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_assertion wasDerivedFrom befree-2016 NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_provenance.
- NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_assertion wasGeneratedBy ECO_0000203 NP1239844.RAwb8MBs17OXLUYHswTmdP-evnNa_LlRqAsGtWpVYQwtE130_provenance.